EBV Ab to Viral Capsid Antigen, IgM




Test Mnemonic

EBVM

CPT Codes

  • 86665 - QTY (1)

LOINC ®

7886-5

Aliases

  • Epstein Barr Ab to Viral Capsid Ag, IgM
  • Epstein Barr Virus IgM Ab to Viral Capsid Antigen,

Performing Laboratory

Cleveland Clinic Laboratories


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mLSerumSST (Gold) Refrigerated 

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
0.5 mL     

Stability

Environmental Condition Description
Ambient24 hours
Refrigerated7 days
Frozen14 days

Days Performed

Sun - Fri

Turnaround Time

1 - 2 days

Methodology

Name Description
Chemiluminescence Immunoassay (CLIA) 

Reference Range

EBV Ab to Viral Capsid Antigen, IgM
Sex Age From Age To Type Range Range Unit
       NormalRefer to reportU/mL

Special Info

Avoid hemolysis. Avoid multiple freeze thaw cycles.

Clinical Info

The test is used as an aid in diagnosing recent EBV infection. It should ne done in conjunction with EBV VCA IgG and EBV nuclear antigen IgG tests. Clinical correlation is required.

Clinical Limitation

Assay performance has not been established for immunocompromised or immunosuppressed patients. Assay performance has not been established for cord blood, neonatal specimens or infants. Due to a degree of observed cross-reactivity in some CMV and Toxo IgM positive samples, samples positive for these analytes should be interpreted with caution. Assay performance has not been established for the diagnosis of nasopharyngeal carcinoma, Burkitt's lymphoma, other EBV-associated lymphomas, and other EBV associated diseases other than EBV related mononucleosis. Testing should not be performed as a screening procedure for the general population. It should only be performed when clinical evidence suggests the diagnosis of EBV-associated infectious mononucleosis. In cases of equivocal results, a second freshly collected sample should be obtained and tested.